These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
315 related articles for article (PubMed ID: 2144582)
21. Cerebrospinal fluid levels of kynurenine pathway metabolites in patients with eating disorders: relation to clinical and biochemical variable. Demitrack MA; Heyes MP; Altemus M; Pigott TA; Gold PW Biol Psychiatry; 1995 Apr; 37(8):512-20. PubMed ID: 7542489 [TBL] [Abstract][Full Text] [Related]
22. Decreased levels of kynurenic acid in prefrontal cortex in a genetic animal model of depression. Liu XC; Erhardt S; Goiny M; Engberg G; Mathé AA Acta Neuropsychiatr; 2017 Feb; 29(1):54-58. PubMed ID: 27406788 [TBL] [Abstract][Full Text] [Related]
23. Possibility of Amino Acid Treatment to Prevent the Psychiatric Disorders via Modulation of the Production of Tryptophan Metabolite Kynurenic Acid. Fukuwatari T Nutrients; 2020 May; 12(5):. PubMed ID: 32414200 [TBL] [Abstract][Full Text] [Related]
24. Dopamine receptor activation reveals a novel, kynurenate-sensitive component of striatal N-methyl-D-aspartate neurotoxicity. Poeggeler B; Rassoulpour A; Wu HQ; Guidetti P; Roberts RC; Schwarcz R Neuroscience; 2007 Aug; 148(1):188-97. PubMed ID: 17629627 [TBL] [Abstract][Full Text] [Related]
25. Indolic and kynurenine pathway metabolites of tryptophan in rat brain: effect of precursor availability on in vivo release. During MJ; Heyes MP; Freese A; Swartz KJ; Matson WR; Markey SP; Martin JB; Roth RH Adv Exp Med Biol; 1991; 294():535-9. PubMed ID: 1837690 [No Abstract] [Full Text] [Related]
26. Chronic Mild Stress Alters Kynurenine Pathways Changing the Glutamate Neurotransmission in Frontal Cortex of Rats. Martín-Hernández D; Tendilla-Beltrán H; Madrigal JLM; García-Bueno B; Leza JC; Caso JR Mol Neurobiol; 2019 Jan; 56(1):490-501. PubMed ID: 29725904 [TBL] [Abstract][Full Text] [Related]
27. Abnormal Activation of Tryptophan-Kynurenine Pathway in Women With Polycystic Ovary Syndrome. Wang S; Mu L; Zhang C; Long X; Zhang Y; Li R; Zhao Y; Qiao J Front Endocrinol (Lausanne); 2022; 13():877807. PubMed ID: 35721725 [TBL] [Abstract][Full Text] [Related]
29. An expanding range of targets for kynurenine metabolites of tryptophan. Stone TW; Stoy N; Darlington LG Trends Pharmacol Sci; 2013 Feb; 34(2):136-43. PubMed ID: 23123095 [TBL] [Abstract][Full Text] [Related]
30. Kynurenine pathway and white matter microstructure in bipolar disorder. Poletti S; Myint AM; Schüetze G; Bollettini I; Mazza E; Grillitsch D; Locatelli C; Schwarz M; Colombo C; Benedetti F Eur Arch Psychiatry Clin Neurosci; 2018 Mar; 268(2):157-168. PubMed ID: 27619930 [TBL] [Abstract][Full Text] [Related]
31. The immune effects of TRYCATs (tryptophan catabolites along the IDO pathway): relevance for depression - and other conditions characterized by tryptophan depletion induced by inflammation. Maes M; Mihaylova I; Ruyter MD; Kubera M; Bosmans E Neuro Endocrinol Lett; 2007 Dec; 28(6):826-31. PubMed ID: 18063923 [TBL] [Abstract][Full Text] [Related]
32. Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders. Sas K; Robotka H; Toldi J; Vécsei L J Neurol Sci; 2007 Jun; 257(1-2):221-39. PubMed ID: 17462670 [TBL] [Abstract][Full Text] [Related]
33. 3-Hydroxykynurenine and quinolinate: pathogenic synergism in early grade Huntington's disease? Guidetti P; Schwarcz R Adv Exp Med Biol; 2003; 527():137-45. PubMed ID: 15206726 [TBL] [Abstract][Full Text] [Related]
34. Age-dependent alterations of the kynurenine pathway in the YAC128 mouse model of Huntington disease. Mazarei G; Budac DP; Lu G; Adomat H; Tomlinson Guns ES; Möller T; Leavitt BR J Neurochem; 2013 Dec; 127(6):852-67. PubMed ID: 23786539 [TBL] [Abstract][Full Text] [Related]
35. Activation of the kynurenine pathway is associated with striatal volume in major depressive disorder. Savitz J; Dantzer R; Meier TB; Wurfel BE; Victor TA; McIntosh SA; Ford BN; Morris HM; Bodurka J; Teague TK; Drevets WC Psychoneuroendocrinology; 2015 Dec; 62():54-8. PubMed ID: 26232650 [TBL] [Abstract][Full Text] [Related]
36. Excitotoxic lesions of the rat striatum: different responses of kynurenine pathway enzymes during ontogeny. Ceresoli G; Fuller MS; Schwarcz R Brain Res Dev Brain Res; 1996 Mar; 92(1):61-9. PubMed ID: 8861723 [TBL] [Abstract][Full Text] [Related]
38. [Kynurenine and its metabolites in nervous system diseases]. Vécsei L; Schwab F Orv Hetil; 1992 Jul; 133(29):1803-7. PubMed ID: 1386152 [TBL] [Abstract][Full Text] [Related]
39. Reversal of imbalance between kynurenic acid and 3-hydroxykynurenine by antipsychotics in medication-naïve and medication-free schizophrenic patients. Myint AM; Schwarz MJ; Verkerk R; Mueller HH; Zach J; Scharpé S; Steinbusch HW; Leonard BE; Kim YK Brain Behav Immun; 2011 Nov; 25(8):1576-81. PubMed ID: 21620952 [TBL] [Abstract][Full Text] [Related]
40. Neostriatal and cortical quinolinate levels are increased in early grade Huntington's disease. Guidetti P; Luthi-Carter RE; Augood SJ; Schwarcz R Neurobiol Dis; 2004 Dec; 17(3):455-61. PubMed ID: 15571981 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]